Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
CHENGDU, China, Aug. 31 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co. Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced that it will present at the Rodman & Renshaw Annual Globa...
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
Both Products to Be Manufactured in Company's New Facility CHENGDU, China, Aug. 13 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has r...
Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
CHENGDU, China, July 8 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today declared a quarterly cash dividend to be paid to its common stock shareholders. The divi...
Tianyin Pharmaceutical Co., Inc. Launches Advertising Program on China Central Television (CCTV) for its Xuelian Chongcao Oral Liquid
Initiative Expected to Contribute $4.4 Million in Revenues for Fiscal 2010 CHENGDU, China, June 29 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced t...
Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index
CHENGDU, China, June 22 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it is set to join the Russell Microcap(R) Index when, according to a preli...
Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance
CHENGDU, China, June 18/ PRNewswire-Asia-FirstCall/ -- -- Management expects to report revenues of approximately $42 million and net income of approximately $7.5 million for the Fiscal Year which ends June 30, 2009. Fourth quarter revenue and net income of appr...
Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
CHENGDU, China, May 15 /PRNewswire-Asia/ -- - Third Quarter 2009 Revenue Increased 7.4% to $9.9 Million while Net Income Increased 48.8% to $1.9 Million with EPS of $0.10 - Revenue for the First Nine Months Increased 22.4 % to $29.6 Million, Net Income Increased 29.2% ...
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDT
CHENGDU, China, May 11 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that management will hold a conference call to discuss its 2009 fiscal third qu...
Tianyin Pharmaceutical Co. Inc. Completes Construction of New Production Facility
CHENGDU, China, May 7 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has completed construction of their new production facility in Chengdu a...
Tianyin Pharmaceutical Co. Inc.'s Ginkgo Mihuan Oral Solution Completes 2009 Tenders
Company also to Consolidate Provincial Distributors to Streamline Sales and Improve Receivables CHENGDU, China, April 21 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, C...
Tianyin Pharmaceutical Co., Inc. Series A Preferred Shareholders Approved Cash Dividend to Common Stockholders
CHENGDU, China, April 14 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that its Series A Preferred shareholders approved an annual cash dividend of ...
Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
CHENGDU, China, March 26 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Board of Directors declared an annual cash dividend of $0.10 per com...
Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
Company Expects 367% Increase in Monthly Revenue Generated by the Drug Increased Market Share to Drive Approximately $3.7 million in Revenue Growth During Next 12 Months CHENGDU, China, March 17 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a manufacturer a...
Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2009 Financial Results
-- Second Quarter 2009 Revenue Increased 30.4% to $10.1 Million and Net Income Increased 24.5% to $2.1 Million -- Q2 2009 Gross Margins Improved 990-Basis Points to 51% over Q2 2008 -- On December 31, 2008 the Company had $12.7 million in cash and equivalents, and...
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
CHENGDU, China, Feb. 11 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that management will hold a conference call to discuss its 2009 fiscal second quart...
Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program
Company Completes Installation of Steel Framework and Roofing for the New GMP Facility CHENGDU, China, Jan. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengd...
Tianyin Pharmaceutical Co., Inc. Receives Production License to Launch Tongbianling Capsules
-- Market Launch Creates New Growth Opportunities For Treating Abdominal Pain and Constipation -- Company Reiterates Fiscal Year 2009 Guidance CHENGDU, China, Dec. 22 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of mod...
Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
Strategy Implemented to Further Diversify Customer Base and Optimize Distribution Channels CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE EuroNext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Che...
Tianyin Pharmaceutical Co., Inc. to Present at ROTH China Comes to Vegas Conference in Las Vegas on November 21, 2008 at 10:30 a.m. PST
CHENGDU, China, Nov. 17 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Company will present at the ROTH Capital Partners Second Annua...
Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
-- First Quarter 2009 Revenue Increased 33.4% to $9.6 Million and Net Income Increased 10.9% to $1.8 Million -- First Quarter 2009 Gross Margins Improved 1090-Basis Point to 51% over First Quarter 2008 -- Company Received Chinese SFDA Approval for Fuke Zhidai Tablets CHENGDU, China,...
